Physician profile
Kun Pan
NPI 1962963652
$2,774.67
in general payments reported to CMS, 2019-2025
18 companies · $962 in 2025
The $962 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $698 · 2024: $1,115 · 2025: $962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,774.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $531.00 | 2023-2025 | |
| Novo Nordisk INC | $491.99 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Exact Sciences Corporation | $483.83 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $294.10 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Amgen INC. | $247.66 | 2023-2025 | Otezla, Repatha, Repatha |
| Pfizer INC. | $153.97 | 2024-2025 | |
| Abbott Laboratories | $120.99 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Abbvie INC. | $87.34 | 2025 | |
| Myriad Women'S Health, INC. | $73.42 | 2023 | Myrisk |
| Phathom Pharmaceuticals, INC. | $60.33 | 2024-2025 | Voquezna |
| Genzyme Corporation | $53.51 | 2024-2025 | |
| Hologic Sales and Service, LLC | $41.40 | 2024 | Aptima, Thinprep 2000 Processor |
| Dexcom, INC. | $36.83 | 2024 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $23.13 | 2025 | Inspire |
| Renalytix Ai, INC. | $20.07 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $18.99 | 2025 | Fasenra |
| Nevro Corp. | $18.46 | 2024 | Senza |
| E.R. Squibb & Sons, L.L.C. | $17.65 | 2025 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kun Pan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.